It's never too late: Smoking cessation after stereotactic body radiation therapy for non-small cell lung carcinoma improves overall survival

Practical Radiation Oncology

Volumn 6, Issue 1, 2016, Pages 12-18

  Roach, Michael C ^a   Rehman, Sana ^a   DeWees, Todd A ^a   Abraham, Christopher D ^a   Bradley, Jeffrey D ^a   Robinson, Cliff G ^a  

^a Washington University in St Louis School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER CONTROL; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER REGISTRY; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; DISEASE COURSE; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SMOKING CESSATION; STEREOTACTIC BODY RADIATION THERAPY; VERY ELDERLY; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIMODAL IMAGING; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RADIOSURGERY; RADIOTHERAPY DOSAGE; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIOSURGERY; RADIOTHERAPY DOSAGE; SMOKING CESSATION; SURVIVAL RATE;

EID: 84952981121     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2015.09.005     Document Type: Article

References (30)

1. World Cancer Report 2014. International Agency for Research on Cancer 2014, World Health Organization, Lyon, France. B.W. Stewart, C.P. Wild (Eds.).
2. Jha P., Ramasundarahettige C., Landsman V., Rostron B., Thun M., Anderson R.N., et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013, 368:341-350.
3. Garces Y.I., Yang P., Parkinson J., Zhao X., Wampfler J.A., Ebbert J.O., et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest 2004, 126:1733-1741.
4. Zhang J., Kamdar O., Le W., Rosen G.D., Upadhyay D. Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer. Am J Respir Cell Mol Biol 2009, 40:36-45.
5. Hughes A.N., O'Brien M.E., Petty W.J., Chick J.B., Rankin E., Woll P.J., et al. Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers. J Clin Oncol 2009, 27:1220-1226.
6. Videtic G.M., Stitt L.W., Dar A.R., Kocha W.I., Tomiak A.T., Truong P.T., et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol 2003, 21:1544-1549.
7. Hung J.J., Jeng W.J., Hsu W.H., Chou T.Y., Huang B.S., Wu Y.C. Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer. J Thorac Oncol 2012, 7:1115-1123.
8. Parsons A., Daley A., Begh R., Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: Systemic review of observational studies with meta-analysis. BMJ 2010, 340:b5569.
9. Robinson C.G., DeWees T.A., El Naga I.M., Creach K.M., Olsen J.R., Crabtree J.D., et al. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small cell lung cancer. J Thorac Oncol 2013, 8:192-201.
10. Koshy M., Malik R., Mahmood U., Husain Z., Sher D.J. Stereotactic body radiotherapy and treatment at a high volume facility is associated with improved survival in patients with inoperable stage I non-small cell lung cancer. Radiother Oncol 2015, 114:148-154.
11. Chang J.Y., Senan S., Paul M.A., Mehran R.J., Louie A.V., Balter P., et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: A pooled analysis of two randomized trials. Lancet Oncol 2015, 16:630-637.
12. Timmerman R., Paulus R., Galvin J., Michalski J., Straube W., Bradley J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303:1070-1076.
13. Hildebrand J.R., Sastry S. Stop smoking! Do we say it enough?. J Oncol Pract 2013, 9:230-232.
14. Amato K.D., Hyland A., Reed R., Mahoney M.C., Marshall J., Giovino G., et al. Tobacco cessation may improve lung cancer patient survival. J Thorac Oncol 2015, 10:1014-1019.
15. Jiménez-Ruiz C.A., Andreas S., Lewis K.E., Tonnesen P., van Schayck C.P., Hajek P., et al. Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. Eur Respir J 2015, 46:61-79.
16. Clair C., Rigotti N.A., Porneala B., Fox C.S., D'Agostino R.B., Pencina M.J., et al. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA 2013, 309:1014-1021.
17. Poghosyan H., Sheldon L.K., Leveille S.G., Cooley M.E. Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: A systematic review. Lung Cancer 2013, 81:11-26.
18. Daniel M., Keefe F.J., Lyna P., Peterson B., Garst J., Kelley M., et al. Persistent smoking after the diagnosis of lung cancer is associated with higher reported pain levels. J Pain 2009, 10:323-328.
19. Ditre J.W., Gonzalez B.D., Simmons V.N., Faul L.A., Brandon T.H., Jacobsen P.B. Associations between pain and current smoking status among cancer patients. Pain 2011, 152:60-65.
20. Berg C.J., Thomas A.N., Mertens A.C., Schauer G.L., Pinsker E.A., Ahluwalia J.S., et al. Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psychooncology 2013, 22:799-806.
21. Stephens K.L., Djemil T., Tendulkar R.D., Robinson C.G., Reddy C.A., Videtic G.M. Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT). Int J Radiat Oncol Biol Phys 2012, 82:974-980.
22. Sobus S.L., Warren G.W. The biologic effects of cigarette smoke on cancer cells. Cancer 2014, 120:3617-3626.
23. Chernyavsky A.I., Shchepotin I.B., Galitovkiy V., Grando S.A. Mechanisms of tumor-promoting activities of nicotine in lung cancer: Synergistic effects of cell membrane and mitochondrial nicotinic acetylcholine receptors. BMC Cancer 2015, 15:152.
24. Park E.R., Japuntich S., Temel J., Lanuti M., Pandiscio J., Hilgenberg J., et al. A smoking cessation intervention for thoracic surgery and oncology clinics: A pilot trial. J Thorac Oncol 2011, 6:1059-1065.
25. Westmaas J.L., Newton C.C., Stevens V.L. Does a recent cancer diagnosis predict smoking cessation? An analysis from a large prospective US cohort. J Clin Oncol 2015, 33:1647-1652.
26. Westmaas J.L., Alcaraz K.I., Berg C.J., Stein K.D. Prevalence and correlates of smoking and cessation-related behavior among survivors of ten cancers: Findings from a nationwide survey nine years after diagnosis. Cancer Epidemiol Biomarkers Prev 2014, 23:1783-1792.
27. Warren G.W., Marshall J.R., Cummings K.M., Toll B., Gritz E.R., Hutson A., et al. Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients. J Thorac Oncol 2013, 8:543-548.
28. Weaver K.E., Danhauer S.C., Tooze J.A., Blackstock A.W., Spangler J., Thomas L., et al. Smoking cessation counseling beliefs and behaviors of outpatient oncology providers. Oncologist 2012, 17:455-462.
29. Stead L.F., Buitrago D., Preciado N., Sanchez G., Hartmann-Boyce J., Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev 2013, 5.
30. Toll B.A., Rojewski A.M., Duncan L.R., Latimer-Cheung A.E., Fucito L.M., Boyer J.L., et al. "Quitting smoking will benefit your health": The evolution of clinician messaging to encourage tobacco cessation. Clin Cancer Res 2014, 20:301-309.